Savic Zeljka,Vracaric Vladimir T,Hadnadjev Ljiljana,Petrovic Zora P,Damjanov Dragomir (2011) Experience in the treatment of some complications of portal hypertension in alcoholic liver cirrhosis, VOJNOSANITETSKI PREGLED, vol. 68, br. 11, str. 917-922 (Article) Petrovic Zora P,Tarabar Dino K,Doder Radoje (2009) Systemic chemotherapy with capox plus bevacizumab in patients with potentally resectable liver metastases from colorectal cancer, ANNALS OF ONCOLOGY, vol. 20, br. , str. 45-45 (Meeting Abstract) Tarabar Dino K,Knezevic-Usaj Slavica F,Cuk Vladimir M,Jovanovic Dusan,Petrovic Zora P (2007) Prognostic value of thymidylate synthase, epidermal growth factor receptors and vascular endothelial growth factor in patients with stage III colon cancer, ANNALS OF ONCOLOGY, vol. 18, br. , str. VII87-VII87 (Meeting Abstract) Tarabar Dino K,Petrovic Zora P,Brocic Tanja P,Doder Radoje (2006) Combined systemic and local immunochemotherapy improves outcome of systemic chemotherapy in treatment of unresectable colorectal liver metasteses, ANNALS OF ONCOLOGY, vol. 17, br. , str. 79-79 (Meeting Abstract) Petrovic Zora P,Tarabar Dino K,Doder Radoje,Tasic Olga,Tufegdzic Ivana Z (2006) Influence of VEGF expression on response to therapy with EGFR inhibitor in patients with EGFR negative liver metastases from colorectal carcinoma, ANNALS OF ONCOLOGY, vol. 17, br. , str. 76-76 (Meeting Abstract) Petrovic Zora P,Tarabar Dino K,Doder Radoje (2006) HER2/neu expresion in EGFR negative colorectal cancer liver metastases and influence on response to systemic chemotherapy, ANNALS OF ONCOLOGY, vol. 17, br. , str. 43-43 (Meeting Abstract) Tarabar Dino K,Petrovic Zora P,Doder Radoje (2006) Combined systemic and local immunochemotherapy improves outcome of systemic chemotherapy in treatment of unresectable colorectal liver metastases, ANNALS OF ONCOLOGY, vol. 17, br. , str. - (Meeting Abstract) Tarabar Dino K,Petrovic Zora P,Brocic Tanja P,Roganovic Branka B,Perisic Nenad,Doder Radoje,Jovic Jasna Z,Peric Sasa,Ristic V,Lukacevic S (2001) Prolonged three year survival after adjuvant chemotherapy with UFT/Leukovorin for II, IIIA and IIIB diffuse gastric cancer, GASTROENTEROLOGY, vol. 120, br. 5, str. A612-A612 (Meeting Abstract)